We detected a large amount of glypican 3 (GPC3)—one of the most frequently expressed known TAAs in human HCC (203)—suggesting that GPC3 could be responsible for CD8+ T cell infiltration and activation in the tumor bed (Figure 2) (136). The gene discussed is CD8A; the disease is hepatocellular carcinoma.